JP2025535447A5 - - Google Patents
Info
- Publication number
- JP2025535447A5 JP2025535447A5 JP2025522938A JP2025522938A JP2025535447A5 JP 2025535447 A5 JP2025535447 A5 JP 2025535447A5 JP 2025522938 A JP2025522938 A JP 2025522938A JP 2025522938 A JP2025522938 A JP 2025522938A JP 2025535447 A5 JP2025535447 A5 JP 2025535447A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- acid sequence
- seq
- sequence shown
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2022126273 | 2022-10-19 | ||
| CNPCT/CN2022/126273 | 2022-10-19 | ||
| CNPCT/CN2023/118363 | 2023-09-12 | ||
| CN2023118363 | 2023-09-12 | ||
| PCT/CN2023/125253 WO2024083161A1 (en) | 2022-10-19 | 2023-10-18 | Antibody-drug conjugate, preparation method and use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025535447A JP2025535447A (ja) | 2025-10-24 |
| JP2025535447A5 true JP2025535447A5 (https=) | 2025-11-04 |
Family
ID=90737003
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025522938A Pending JP2025535447A (ja) | 2022-10-19 | 2023-10-18 | 抗体－薬物コンジュゲート、その調製方法および使用 |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP4605015A1 (https=) |
| JP (1) | JP2025535447A (https=) |
| KR (1) | KR20250080903A (https=) |
| CN (1) | CN120091834A (https=) |
| AU (1) | AU2023362056A1 (https=) |
| IL (1) | IL320035A (https=) |
| MX (1) | MX2025004492A (https=) |
| TW (1) | TW202430221A (https=) |
| WO (1) | WO2024083161A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2026037321A1 (en) * | 2024-08-13 | 2026-02-19 | Lepu Biopharma Co., Ltd. | Compounds, compositions and methods |
| CN120369658B (zh) * | 2025-06-26 | 2025-08-29 | 凯莱英生命科学技术(天津)有限公司 | 测定抗体偶联药物中毒素连接子的消光系数的方法及检测抗体偶联药物中药物抗体偶联比的方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7381478B2 (ja) * | 2017-10-23 | 2023-11-15 | マブリンク ビオシオンス | 単一分子量ポリサルコシンを含むリガンド－薬物－複合体 |
| WO2020132190A1 (en) * | 2018-12-21 | 2020-06-25 | Multitude Inc. | Antibodies specific to muc18 |
| AU2020216780B2 (en) * | 2019-01-28 | 2025-05-08 | Multitude Therapeutics Inc. | Antibodies specific to CD44 |
| KR20220024106A (ko) * | 2019-05-20 | 2022-03-03 | 노파르티스 아게 | Mcl-1 억제제 항체-약물 접합체 및 사용 방법 |
| AU2021284401A1 (en) * | 2020-06-05 | 2023-01-05 | Eisai R&D Management Co., Ltd. | Anti-BCMA antibody-drug conjugates and methods of use |
-
2023
- 2023-10-18 KR KR1020257016318A patent/KR20250080903A/ko active Pending
- 2023-10-18 JP JP2025522938A patent/JP2025535447A/ja active Pending
- 2023-10-18 IL IL320035A patent/IL320035A/en unknown
- 2023-10-18 CN CN202380073560.7A patent/CN120091834A/zh active Pending
- 2023-10-18 WO PCT/CN2023/125253 patent/WO2024083161A1/en not_active Ceased
- 2023-10-18 EP EP23879149.5A patent/EP4605015A1/en active Pending
- 2023-10-18 AU AU2023362056A patent/AU2023362056A1/en active Pending
- 2023-10-18 TW TW112139754A patent/TW202430221A/zh unknown
-
2025
- 2025-04-15 MX MX2025004492A patent/MX2025004492A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021102648A (ja) | 抗ｆｏｌｒ１免疫複合体投与計画 | |
| KR102923527B1 (ko) | 생체활성 분자 접합체, 이의 제조 방법 및 용도 | |
| JP7191938B2 (ja) | Ｉｇｆ－１ｒモノクローナル抗体及びその使用 | |
| EP3151865B1 (en) | Site-specific conjugation of linker drugs to antibodies and resulting adcs | |
| JP2023512036A5 (https=) | ||
| US20250297004A1 (en) | Nectin-4 binding agents | |
| JP2025535447A5 (https=) | ||
| US20190298846A1 (en) | Cell targeting conjugates | |
| CN120393061A (zh) | 放射性免疫缀合物与dna损伤和修复抑制剂组合疗法 | |
| KR20230145162A (ko) | 표적 전달 이용을 위한 2가 섬유모세포 활성화 단백질 리간드 | |
| US20240366782A1 (en) | Means and methods for producing antibody-linker conjugates | |
| CN112168978B (zh) | 一种抗体偶联药物及其药物组合物与应用 | |
| WO2021228044A1 (en) | Drug conjugates containing alpha-enolase antibodies and uses thereof | |
| TW201905000A (zh) | 含有抗globo h抗體之抗體－藥物共軛物及其用途 | |
| WO2015114166A2 (en) | Targeted drug conjugates | |
| JP2025533983A (ja) | リンカー－ペイロード化合物、複合体、及びその用途 | |
| US20240091372A1 (en) | Anti-doppel antibody drug conjugates | |
| WO2025118472A1 (zh) | 一种抗met/egfr双特异性抗体及其药物偶联物 | |
| CN119907809A (zh) | Dll3抗原结合构建体 | |
| US20240269313A1 (en) | Conjugates comprising a phosphorus(v) moiety and a drug | |
| WO2025043019A1 (en) | Slc4a1 (band 3) binding single domain antibodies for increased blood retention | |
| HK40058007A (en) | Site-specific conjugation of linker drugs to antibodies and resulting adcs | |
| WO2026092701A1 (zh) | 一种抗体-药物偶联物及其制备方法和用途 | |
| TW202506190A (zh) | 利用抗ｍｕｃ１抗體－藥物結合物投予的藥劑低敏感性癌之治療方法 | |
| KR20250034273A (ko) | 항-도펠 항체-약물 접합체 |